Slide 1: Letter to stock exchanges on Q1 presentation
August 16, 2021 The DCS - CRD BSE Limited National Stock Exchange of India Ltd Corporate Relationship Department Exchange Plaza, C-1, Block G, 1st Floor, New Trading Ring, Bandra Kurla Complex, Rotunda Building, P. J. Towers, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Dear Sir /
Slide 2: Borosil Limited - Investor Presentation Q1FY22
Borosil Limited - Investor Presentation Q1FY22 Borosil Investor presentation - Q1FY22 01
Slide 3: Safe harbour statement
Safe harbour statement “This investor presentation has been prepared by Borosil Limited (“Borosil” or “Company”) on a strictly Borosil Investor presentation - Q1FY22 02
Slide 4: About Borosil
About Borosil Brand with a years of Borosil 50+year legacy Market Leader- Microwavable Kitchenware in India (Consumer Products) Market Leader- Laboratory Glassware Borosil Investor presentation - Q1FY22 03
Slide 5: Vision
Vision To be the most customer-centric company in India Borosil Investor presentation - Q1FY22 04
Slide 6: Re-Imagining Consumer
Re-Imagining Consumer Glass Products Consumer Brands Company Company Occasional Use Daily Use (Dinnerware, (Microwavable) Storage, Appliances) - Single Brand Adding brands - - General Trade General Trade Modern Trade E-Commerce Borosil Investor presentation - Q1FY22 05
Slide 7: Three Brands
Three Brands Single Brand BOROSIL BOROSIL LabQuest Klasspack Lab Glassware Lab Glassware only Lab Instruments Pharma Packaging Domestic Business Domestic Business International Business Borosil Investor presentation - Q1FY22 06
Slide 8: Journey over last 8 years
Journey over last 8 years Sales CAGR: 20% CAGR: 29% 585 90 2020-21 2020-21 135 2012-13 12 2012-13 Borosil Investor presentation - Q1FY22 07
Slide 9: Financial Overview Q1FY22 (consolidated)
Financial Overview Q1FY22(consolidated) INR Crore Q1 FY21 Q1 FY22 Growth % Net Sales 56.10 137.88 145.8% EBITDA (1.53) 19.42 1367.7% EBITDA 2.08 25.45 1125.4% (Before one-time items) PBT (10.53) 10.70 201.7% PAT (7.36) (1.90) 74.2% Net Cash (Period end) 94.74 245.57 Borosil Investor presentation - Q
Slide 10: Category wise sales (Consumerware)
Category wise sales (Consumerware) INR Crore Category Q1 FY21 Q1 FY22 Growth % Glassware 8.36 22.39 167.9% Non Glassware 7.24 28.95 299.8% Opalware 4.08 32.40 693.2% Total Consumerware 19.68 83.73 325.4% Borosil Investor presentation - Q1FY22 09
Slide 11: Category wise sales (Scientific)
Category wise sales (Scientific) INR Crore Category Q1 FY21 Q1 FY22 Growth % Laboratory Glassware 20.24 28.18 39.2% Lab Instrumentation 2.45 4.24 72.9% Pharma Packaging 13.73 21.74 58.4% Total Scientific 36.41 54.15 48.7% Borosil Investor presentation - Q1FY22 10
Slide 12: Cost and EBITDA margin (consolidated business)
(consolidated business) % of Net Revenue Q1 FY21 Q1 FY22 Advertising & Sales 1.8% 4.5% Promotion (ASP) Personnel Costs 34.9% 16.3% EBITDA Margin 0.8% 15.2% (before one-time items) EBITDA Margin before 2.6% 19.8% ASP & one time items Borosil Investor presentation - Q1FY22 11
Slide 13: Capital Employed (Standalone)
Capital Employed (Standalone) INR Crore Consumerware Scientific Borosil FY20 FY21 FY20 FY21 FY20 FY21 Working Capital 170 115 58 56 44 102 Employed Working Capital 105 97 55 130 113 71 (Days of Sales) Operating Capital 311 223 142 103 453 327 Employed Goodwill * 59 59 Strategic Investments ** 67 67 N
Slide 14: Consumer Division
Consumer Division Borosil Investor presentation - Q1FY22 13
Slide 15: Storage, Cooking & Serving needs of a modern kitchen
Storage, Cooking & Serving needs of a modern kitchen Cook Serve Store Cut, Chop, Cook, Bake, Grind, Mix Toast, Grill • Contemporary • • Everyday Use • • • • • Borosil Investor presentation - Q1FY22 14
Slide 16: Consumer Products
Consumer Products Market Growth % Glass Microwaveables 100 10% Tumblers 440 10% Storage 15% to 20% Opalware 500 20% 15% Domestic Appliances 9000 10% Note : Market size, growth & share are internal estimates Borosil Investor presentation - Q1FY22 15
Slide 17: Borosil - Ally of Progressive Homemaker
Borosil - Ally of Progressive Homemaker #Morning Preps, Chai, Breakfast, 6 AM Appliances Storage Cookware Dinnerware #Lunch 9 AM Husband, #Dinner Prep, Kids Evening Tea, 9 PM Dinner Serving Lunch Box Heat & Serve Wet storage 6 PM #Social meetings, hi tea, Travel, Workout Borosil Investor presentatio
Slide 18: Trade Partners
Trade Partners Borosil Investor presentation - Q1FY22 17
Slide 19: Trade partners logos
www.ifbappliances.com ..••••• ....... .•····:·:·.... • •. BOSCH \~\TIMES ~ WALLACE PHARMACEUTICAlS PVT. LTD. lnduslnd Bank INTERNET ALKEN ~OCKHAI?DT LiFE W iNS qlenmaRk A new way for a new world A dose of life sPHARMA Borosil Investor presentation - Q1FY22 18
Slide 20: Growth Pillars
Growth Pillars Domestic Appliances Borosil Investor presentation - Q1FY22 19
Slide 21: Category gaining salience
Category gaining salience Larah FY21 revenue INR 141.05 cr Borosil Investor presentation - Q1FY22 20
Slide 22: Storage Range
Storage Range Thoughtful Products creating a new pillar of growth Borosil Investor presentation - Q1FY22 21
Slide 23: Medium-Term Thrust Areas
Medium-Term Thrust Areas 20 Borosil Investor presentation - Q1FY22 22
Slide 24: Borosil Scientific
BOROSII: 1 I 0 • • • -!lj Borosil Investor presentation - Q1FY22 23
Slide 25: Lab Instrumentation
Lab Instrumentation Magnetic Stirrer Glass vials Burettes Block Digester Glass ampoules Pipettes Multi-Tube Vortexer Liquid handling systems Borosil Investor presentation - Q1FY22 24
Slide 26: Lab Glassware, Instrumentation and Pharma Packaging markets
Lab Glassware Lab Pharma Packaging Lab Glassware India Exports Instrumentation (Vials & Ampoules) Market Size (INR Cr) 235 4000 150 235 Est. Market Growth ~8-10% ~0-2% ~8-10% ~10-12% Customers Pharma R&D & QC, Pharma R&D & QC Pharma R&D & QC, Pharma cos Government Labs, Government Labs, Food & Soil
Slide 27: Some key Customers
Some key Customers Borosil Investor presentation - Q1FY22 26
Slide 28: Growth Pillars
Growth Pillars International Core laboratory Become 2nd credible Borosil Investor presentation - Q1FY22 27
Slide 29: Medium-Term Thrust Areas
Medium-Term Thrust Areas 10 Maintain EBITDA Margins Borosil Investor presentation - Q1FY22 28
Slide 30: Laboratory Glassware
Laboratory Glassware -- Meeting wide product range need of customer -- -- - Single supplier convenient for laboratory for multiple critical yet low ticket SKUs - - Not easily replicable by competition Quick & on-time delivery of SKU range - Investment in inventory, 6 warehouses & dealer network - We
Slide 31: Primary Packaging for Pharma
Primary Packaging for Pharma Glass Ampoules & Tubular Glass Vials for packaging pharmaceutical products Complements Borosil’s analytical vials range (used in the lab) Provides Borosil’s Pharmaceutical Customers credible 2nd alternative for their packaging needs more entrants COVID 19 opening many ma
Slide 32: Key Enablers & Capabilities in Consumer business
Key Enablers & Capabilities in Consumer business Borosil Investor presentation - Q1FY22 31
Slide 33: Shreevar Kheruka, Chairman
Shreevar Kheruka Chairman Borosil Investor presentation - Q1FY22 32
Slide 34: Shareholding pattern
11,41,19,467 2.0% 0.2% Other 1369812D:IN BOROLTD 543212 27.3% Others INR 2498 Cr Promoters as on - 30 Jun 2021 : Borosil Investor presentation - Q1FY22 33
Slide 35: Investor Relations
Borosil Limited 1101, Crescenzo,G-Block, Opposite MCA Club, Bandra Kurla Complex Bandra (East), Mumbai - 400 051. India www.borosil.com www.myborosil.com Investor Relations: (anand.sultania@borosil.com) Borosil Investor presentation - Q1FY22 34
Slide 36: borosil.com myborosil.com
borosi/.com I myborosil.com -- -- -- r - " ' ' / -- -- l - " -- - l - - l -- - -- r -- " - - Borosil Investor presentation - Q1FY22 35